Expression of CtBP family protein isoforms in breast cancer and their role in chemoresistance-Reference-Cited by-同舟云学术

Expression of CtBP family protein isoforms in breast cancer and their role in chemoresistance

Published:2011-01 Issue:1 Volume:103 Page:1-19
ISSN:0248-4900
Container-title:Biology of the Cell
language:en
Short-container-title:

Author:

Birts Charles N.,Harding Rachael,Soosaipillai Gehan,Halder Trisha,Azim-Araghi Ali,Darley Matthew,Cutress Ramsey I.,Bateman Adrian C.,Blaydes Jeremy P.

Publisher

Wiley

Subject

Cell Biology,General Medicine

Reference47 articles.

1. C-terminal binding proteins: emerging roles in cell survival and tumorigenesis;Bergman;Apoptosis,2006

2. Role of the unique N-terminal domain of CtBP2 in determining the subcellular localisation of CtBP family proteins;Bergman;BMC Cell Biol.,2006

3. CtBPs promote cell survival through the maintenance of mitotic fidelity;Bergman;Mol. Cell. Biol.,2009

4. DNA damage triggers DRB-resistant phosphorylation of human p53 at the CK2 site;Blaydes;Oncogene,1998

5. A region in the C-terminus of adenovirus 2/5 E1a protein is required for association with a cellular phosphoprotein and important for the negative modulation of T24-ras mediated transformation, tumorigenesis and metastasis;Boyd;EMBO J,1993

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Computational pipeline predicting cell death suppressors as targets for cancer therapy;iScience;2024-09

2. A new method for network bioinformatics identifies novel drug targets for mucinous ovarian carcinoma;NAR Genomics and Bioinformatics;2024-07-02

3. Toosendanin Restrains Idiopathic Pulmonary Fibrosis by Inhibiting ZEB1/CTBP1 Interaction;Current Molecular Medicine;2024-01

4. CRISPR/Cas9-Mediated CtBP1 Gene Editing Enhances Chemosensitivity and Inhibits Metastatic Potential in Esophageal Squamous Cell Carcinoma Cells;International Journal of Molecular Sciences;2023-09-13

5. CLK2 Expression Is Associated with the Progression of Colorectal Cancer and Is a Prognostic Biomarker;BioMed Research International;2022-07-07